Delivery Order SPE2DB20D3104-SPE2DB23FV4Q0
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NORVASC 5 MG TABLET 90S, a prescription medication, with a ceiling value of $1,392.17 and a performance period through June 30, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $88,734.77 Firm Fixed Price Delivery Order is for the supply of NORVASC 10 MG TABLET 90S, a cardiovascular medication, to support military healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $2,244.76 firm fixed price delivery order is for the supply of NORVASC 10 mg tablets. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to...
- This federal contract award, with ID SPE2DB22D1041|SPE2DB24FTYR3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,121.11 firm-fixed-price delivery order is for the supply of NORVASC 5 MG TABLET 90S, a cardiovascular medication. The contract has an ultimate completion date of December 5, 2023 and was awarded on December 4, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award, worth $4,652.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Norvasc 5 mg tablets, a cardiovascular medication, with a completion date of July 8, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,895.14 firm-fixed-price delivery order is for the supply of 4,565,597,451 units of the prescription drug Norvasc (amlodipine besylate) 5 mg tablets. The contract has an ultimate completion date of August 28, 2024 and does not utilize any set-aside designations. Amerisourcebergen is a major pharmaceutical distributor that...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,761.26 firm fixed-price contract is for the delivery of AMLODIPINE-VALSARTAN 5-320 MG 30S, a cardiovascular medication, and has an ultimate completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,558,165,058 units of the pharmaceutical NORVASC 10 MG TABLET 90S. The $181,695.58 order was placed on August 19, 2022 with an expected completion date of August 22, 2022. This award was not set aside for any specific business type. AmerisourceBergen Drug Corp is a prime contractor that provides pharmaceutical products and...
- This federal contract award, valued at $33,253.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the delivery of Norvasc 2.5 mg tablets, a prescription medication. This is a firm fixed-price delivery order contract with a completion date of January 6, 2023. Amerisourcebergen, a major pharmaceutical distributor in the United States, has been awarded numerous federal contracts to supply a wide...
- This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,222.26 firm fixed-price contract is to provide 4567741879 ! AMLODIPINE-VALSARTAN 5-160 MG 30S, a cardiovascular medication, to support military healthcare programs. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB23FV4Q0Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,093.44 firm-fixed-price contract is for the delivery of NORVASC 2.5 MG TABLET 90S, a cardiovascular medication. The contract is not set aside for any specific business type. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 1/9/23 |